Innoviva, Inc. INVA Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Innoviva, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Innoviva, Inc.'s cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Innoviva, Inc.'s cash & equivalents?
- Innoviva, Inc. (INVA) reported cash & equivalents of $603.09M in Q1 2026.
- How has Innoviva, Inc.'s cash & equivalents changed year-over-year?
- Innoviva, Inc.'s cash & equivalents increased by 89.0% year-over-year, from $319.09M to $603.09M.
- What is the long-term trend for Innoviva, Inc.'s cash & equivalents?
- Over 5 years (2020 to 2025), Innoviva, Inc.'s cash & equivalents has grown at a 17.5% compound annual growth rate (CAGR), from $246.49M to $550.94M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.